News


人材検索

人材検索について

ハイパフォーマンススポーツに係る研究者やサポートスタッフ等の人材情報の検索ができます。HPSCに現在勤務する職員(HPSCスタッフ)、HPSCの勤務経験者(HPSC OB/OG)、HPSCの各種事業における協力者(HPSC事業協力者)のカテゴリーに分けております。人材データベースへのご登録はHPSCからご依頼させて頂いた方のみとしております。

avatar

最終更新日:2024/04/19

清水 和弘

シミズ カズヒロ (Kazuhiro Shimizu)
論文
タイトル
タイトル(英)
Urinary N-terminal fragment of titin: A surrogate marker of serum creatine kinase activity after exercise-induced severe muscle damage.
参照URL
https://researchmap.jp/read0128841/published_papers/31854274
著者
著者(英)
Yoko Tanabe,Kazuhiro Shimizu,Hiroyuki Sagayama,Naoto Fujii,Hideyuki Takahashi
担当区分
概要
概要(英)
We aimed to evaluate whether changes in the noninvasively assessed urinary N-terminal fragment of titin (U-titin) concentration may be associated with those of serum creatine kinase (CK) activity, transverse relaxation time (T2), maximal voluntary contraction (MVC) torque, range of motion (ROM), and muscle soreness, following high-intensity eccentric exercise. Twenty-eight healthy young men performed 30 maximal isokinetic (120°/s) eccentric elbow flexor contractions using an isokinetic dynamometer. U-titin concentration, serum CK activity, T2, MVC torque, ROM, and muscle soreness were measured before and after a maximum of 4 days. Both U-titin concentration and serum CK activity increased post-exercise in a similar manner, though the former elevated slightly earlier (p < 0.05). The peak values of log U-titin concentration following eccentric exercise were strongly correlated with those of log serum CK activity (r = 0.90, p < 0.05) and T2 (r = 0.84, p < 0.05). There were moderate correlations between peak values of U-titin concentration and those of MVC torque (r = 0.69, p < 0.05) and ROM decline rate (r = 0.45, p < 0.05). These results suggest that in healthy young men, the non-invasive marker, U-titin, may be used as a serum CK surrogate following exercise-induced severe muscle damage.
出版者・発行元
出版者・発行元(英)
誌名
誌名(英)
Journal of Sports Sciences
開始ページ
1
終了ページ
8
出版年月
2021年3月16日
査読の有無
査読有り
招待の有無
掲載種別
研究論文(学術雑誌)
ISSN
DOI URL
https://doi.org/10.1080/02640414.2021.1876329
共同研究・競争的資金等の研究課題